Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

MicroRNA miR-125b controls melanoma progression by direct regulation of c-Jun protein expression

Oncogene volume 32, pages 2984–2991 (2013)Cite this article

Subjects

Abstract

A fundamental event in the development and progression of malignant melanoma is the deregulation of cancer-relevant transcription factors. We recently showed that c-Jun is a main regulator of tumor progression in melanoma and thus the most important member of the AP-1 transcription factor family for this disease. Interestingly, we revealed that c-Jun expression was regulated on the post-transcriptional level and therefore speculated that miRNAs could be involved in c-Jun regulation. We determined seed sequences for miR-125b and miR-527 in the coding region of c-Jun mRNA that hints at the direct involvement of miRNA-dependent regulation on the protein level. We found that the expression of miR-125b was significantly reduced in malignant melanoma cell lines and tissue samples compared with melanocytes, whereas miR-527 remained unchanged. In further functional experiments, treatment of melanoma cells with pre-miR-125b resulted in strong suppression of cellular proliferation and migration, supporting the role of miR-125b in melanoma. In addition, transfection of pre-miR-125b led to strong downregulation of c-Jun protein but not mRNA expression in melanoma cells. Luciferase assays using reporter plasmids containing the miR-125b seed sequence in the luciferase coding region confirmed the direct interaction with miR-125b. Furthermore, immunoprecipitation of Ago-2 revealed that c-Jun mRNA accumulated in the RNA-induced silencing complex after pre-miR-125b transfection in melanoma cells. In summary, we identified an important role for miR-125b in malignant melanoma. Moreover, we demonstrated post-transcriptional regulation of c-Jun by this miRNA and showed that c-Jun is a main mediator of the effects of miR-125b on melanoma cells.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5

Similar content being viewed by others

References

  1. Eferl R, Wagner EF . AP-1: a double-edged sword in tumorigenesis. Nat Rev Cancer 2003; 3: 859–868.

    Article  CAS  Google Scholar 

  2. Jochum W, Passegue E, Wagner EF . AP-1 in mouse development and tumorigenesis. Oncogene 2001; 20: 2401–2412.

    Article  CAS  Google Scholar 

  3. Weiss C, Bohmann D . Deregulated repression of c-Jun provides a potential link to its role in tumorigenesis. Cell Cycle 2004; 3: 111–113.

    Article  CAS  Google Scholar 

  4. Spangler B, Vardimon L, Bosserhoff AK, Kuphal S . Post-transcriptional regulation controlled by E-cadherin is important for c-Jun activity in melanoma. Pigment Cell Melanoma Res 2011; 24: 148–164.

    Article  CAS  Google Scholar 

  5. Kovary K, Bravo R . The jun and fos protein families are both required for cell cycle progression in fibroblasts. Mol Cell Biol 1991; 11: 4466–4472.

    Article  CAS  Google Scholar 

  6. Shaulian E, Karin M . AP-1 in cell proliferation and survival. Oncogene 2001; 20: 2390–2400.

    Article  CAS  Google Scholar 

  7. Gebauer F, Hentze MW . Molecular mechanisms of translational control. Nat Rev Mol Cell Biol 2004; 5: 827–835.

    Article  CAS  Google Scholar 

  8. Meister G, Tuschl T . Mechanisms of gene silencing by double-stranded RNA. Nature 2004; 431: 343–349.

    Article  CAS  Google Scholar 

  9. Vasudevan S . Posttranscriptional upregulation by MicroRNAs. Wiley Interdiscip Rev RNA 2012; 3: 311–330.

    Article  CAS  Google Scholar 

  10. Papaconstantinou I, Karakatsanis A, Gazouli M, Polymeneas G, Voros D . The role of microRNAs in liver cancer. Eur J Gastroenterol Hepatol 2012; 24: 223–228.

    Article  CAS  Google Scholar 

  11. Fang YX, Xue JL, Shen Q, Chen J, Tian L . miR-7 inhibits tumor growth and metastasis by targeting the PI3K/AKT pathway in hepatocellular carcinoma. Hepatology 2012; 55: 1852–1862.

    Article  CAS  Google Scholar 

  12. Le XF, Merchant O, Bast RC, Calin GA . The roles of micrornas in the cancer invasion-metastasis cascade. Cancer Microenviron 2010; 3: 137–147.

    Article  CAS  Google Scholar 

  13. Dalmay T, Edwards DR . MicroRNAs and the hallmarks of cancer. Oncogene 2006; 25: 6170–6175.

    Article  CAS  Google Scholar 

  14. Mueller DW, Bosserhoff AK . Role of miRNAs in the progression of malignant melanoma. Br J Cancer 2009; 101: 551–556.

    Article  CAS  Google Scholar 

  15. Howell PM, Li X, Riker AI, Xi Y . MicroRNA in melanoma. Ochsner J 2010; 10: 83–92.

    Google Scholar 

  16. Deng Y, Deng H, Bi F, Liu J, Bemis LT, Norris D et al. MicroRNA-137 targets carboxyl-terminal binding protein 1 in melanoma cell lines. Int J Biol Sci 2011; 7: 133–137.

    Article  CAS  Google Scholar 

  17. Ender C, Meister G . Argonaute proteins at a glance. J Cell Sci 2010; 123: 1819–1823.

    Article  CAS  Google Scholar 

  18. Zeng Y, Yi R, Cullen BR . MicroRNAs and small interfering RNAs can inhibit mRNA expression by similar mechanisms. Proc Natl Acad Sci USA 2003; 100: 9779–9784.

    Article  CAS  Google Scholar 

  19. Janga SC, Vallabhaneni S . MicroRNAs as post-transcriptional machines and their interplay with cellular networks. Adv Exp Med Biol 2011; 722: 59–74.

    Article  CAS  Google Scholar 

  20. Orom UA, Nielsen FC, Lund AH . MicroRNA-10a binds the 5′UTR of ribosomal protein mRNAs and enhances their translation. Mol Cell 2008; 30: 460–471.

    Article  Google Scholar 

  21. Rigoutsos I . New tricks for animal microRNAS: targeting of amino acid coding regions at conserved and nonconserved sites. Cancer Res 2009; 69: 3245–3248.

    Article  CAS  Google Scholar 

  22. Esquela-Kerscher A, Slack FJ . Oncomirs—microRNAs with a role in cancer. Nat Rev Cancer 2006; 6: 259–269.

    Article  CAS  Google Scholar 

  23. Chen J, Feilotter HE, Pare GC, Zhang X, Pemberton JG, Garady C et al. MicroRNA-193b represses cell proliferation and regulates cyclin D1 in melanoma. Am J Pathol 2010; 176: 2520–2529.

    Article  CAS  Google Scholar 

  24. Xu Y, Brenn T, Brown ER, Doherty V, Melton DW . Differential expression of microRNAs during melanoma progression: miR-200c, miR-205 and miR-211 are downregulated in melanoma and act as tumour suppressors. Br J Cancer 2012; 106: 553–561.

    Article  CAS  Google Scholar 

  25. Poser I, Tatzel J, Kuphal S, Bosserhoff AK . Functional role of MIA in melanocytes and early development of melanoma. Oncogene 2004; 23: 6115–6124.

    Article  CAS  Google Scholar 

  26. Russo AE, Torrisi E, Bevelacqua Y, Perrotta R, Libra M, McCubrey JA et al. Melanoma: molecular pathogenesis and emerging target therapies (Review). Int J Oncol 2009; 34: 1481–1489.

    CAS  Google Scholar 

  27. Shoo BA, Kashani-Sabet M . Melanoma arising in African-, Asian-, Latino- and Native-American populations. Semin Cutan Med Surg 2009; 28: 96–102.

    Article  CAS  Google Scholar 

  28. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D . Global cancer statistics. CA Cancer J Clin 2011; 61: 69–90.

    Article  Google Scholar 

  29. Mueller DW, Rehli M, Bosserhoff AK . miRNA expression profiling in melanocytes and melanoma cell lines reveals miRNAs associated with formation and progression of malignant melanoma. J Invest Dermatol 2009; 129: 1740–1751.

    Article  CAS  Google Scholar 

  30. Philippidou D, Schmitt M, Moser D, Margue C, Nazarov PV, Muller A et al. Signatures of microRNAs and selected microRNA target genes in human melanoma. Cancer Res 2010; 70: 4163–4173.

    Article  CAS  Google Scholar 

  31. Calin GA, Sevignani C, Dumitru CD, Hyslop T, Noch E, Yendamuri S et al. Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci USA 2004; 101: 2999–3004.

    Article  CAS  Google Scholar 

  32. Glud M, Rossing M, Hother C, Holst L, Hastrup N, Nielsen FC et al. Downregulation of miR-125b in metastatic cutaneous malignant melanoma. Melanoma Res 2010; 20: 479–484.

    Article  CAS  Google Scholar 

  33. Glud M, Manfe V, Biskup E, Holst L, Dirksen AM, Hastrup N et al. MicroRNA miR-125b induces senescence in human melanoma cells. Melanoma Res 2011; 21: 253–256.

    Article  CAS  Google Scholar 

  34. Poser I, Bosserhoff AK . Transcription factors involved in development and progression of malignant melanoma. Histol Histopathol 2004; 19: 173–188.

    CAS  Google Scholar 

  35. Libermann TA, Zerbini LF . Targeting transcription factors for cancer gene therapy. Curr Gene Ther 2006; 6: 17–33.

    Article  CAS  Google Scholar 

  36. Spangler B, Kappelmann M, Schittek B, Meierjohann S, Vardimon L, Bosserhoff AK et al. ETS-1/RhoC signaling regulates the transcription factor c-Jun in melanoma. Int J Cancer 2012; 130: 2801–2811.

    Article  CAS  Google Scholar 

  37. Friedman RC, Farh KK, Burge CB, Bartel DP . Most mammalian mRNAs are conserved targets of microRNAs. Genome Res 2009; 19: 92–105.

    Article  CAS  Google Scholar 

  38. Bartel DP . MicroRNAs: target recognition and regulatory functions. Cell 2009; 136: 215–233.

    Article  CAS  Google Scholar 

  39. Katiyar S, Casimiro MC, Dettin L, Ju X, Wagner EF, Tanaka H et al. C-jun inhibits mammary apoptosis in vivo. Mol Biol Cell 2010; 21: 4264–4274.

    Article  CAS  Google Scholar 

  40. Braig S, Bosserhoff A-K . Death inducer-obliterator 1 (Dido1) is a BMP target gene and promotes BMP-induced melanoma progression. Oncogene (e-pub ahead of print 2 April 2012; doi:10.1038/onc.2012.115).

    Article  Google Scholar 

  41. Jacob K, Wach F, Holzapfel U, Hein R, Lengyel E, Buettner R et al. In vitro modulation of human melanoma cell invasion and proliferation by all-trans-retinoic acid. Melanoma Res 1998; 8: 211–219.

    Article  CAS  Google Scholar 

  42. Polak P, Oren A, Ben Dror I, Steinberg D, Sapoznik S, Arditi-Duvdevany A et al. The cytoskeletal network controls c-Jun translation in a UTR-dependent manner. Oncogene 2006; 25: 665–676.

    Article  CAS  Google Scholar 

  43. Rothhammer T, Poser I, Soncin F, Bataille F, Moser M, Bosserhoff AK . Bone morphogenic proteins are overexpressed in malignant melanoma and promote cell invasion and migration. Cancer Res 2005; 65: 448–456.

    CAS  Google Scholar 

  44. Braig S, Wallner S, Junglas B, Fuchshofer R, Bosserhoff AK . CTGF is overexpressed in malignant melanoma and promotes cell invasion and migration. Br J Cancer 2011; 105: 231–238.

    Article  CAS  Google Scholar 

  45. Schmid R, Schiffner S, Opolka A, Grassel S, Schubert T, Moser M et al. Enhanced cartilage regeneration in MIA/CD-RAP deficient mice. Cell Death Dis 2010; 1: e97.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We would like to thank Lisa Ellmann for continuous assistance in cultivation. This work was supported by Melanoma Research Network of the Deutsche Krebshilfe e.V. (German Cancer Aid) and the DFG. GM is supported by grants from the Bavarian Ministry for education and science (BayGene), the European Union (ERC starting grant ‘sRNAs’, FP7 project ‘ONCOMIRs’) and the Bundesministerium für Bildung und Forschung (BMBF, NGFN+).

Author information

Authors and Affiliations

  1. Institute of Pathology, University of Regensburg, Regensburg, Germany

    M Kappelmann, S Kuphal & A-K Bosserhoff

  2. Institute of Biochemistry, University of Regensburg, Regensburg, Germany

    G Meister

  3. Department of Biochemistry and Molecular Biology, Tel Aviv University, Tel Aviv, Israel

    L Vardimon

Authors
  1. M Kappelmann
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. S Kuphal
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. G Meister
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. L Vardimon
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. A-K Bosserhoff
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to A-K Bosserhoff.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kappelmann, M., Kuphal, S., Meister, G. et al. MicroRNA miR-125b controls melanoma progression by direct regulation of c-Jun protein expression. Oncogene 32, 2984–2991 (2013). https://doi.org/10.1038/onc.2012.307

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/onc.2012.307

Keywords

This article is cited by

Search

Advanced search

Quick links